Please assess the completion status of the following clinical trial:

Trial Title: ALF-STONE: Alfuzosin in Uretheric Stones

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion criteria:~* Patients with imagiologic evidence of uretheric stones~Exclusion criteria:~* Women pregnant or breast feeding~* Patients with renal impairment (creatinine \> 2mg/dl)~The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.

- Gender: MALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).